Physician profile

Gary Smith

Moon Township, PA

NPI 1932191475

$446.52

in general payments reported to CMS, 2019-2025

7 companies · $107 in 2025

The $107 reported for 2025 was less than what a typical provider received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$274.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $126.66 2019
Novus Surgical Consultants $107.14 2025
Zimmer Biomet Holdings, INC. $94.12 2024
Acumed LLC $73.66 2023 Acumed, Innate Implant
Ferring Pharmaceuticals INC. $21.04 2020
Sanofi Pasteur INC. $13.11 2019
Medline Industries Lp $10.79 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gary Smith

$446.52

in general payments reported 2019-2025

Years
2019-2025
Top company
Smith+Nephew, INC.
Context
The $107 reported for 2025 was less than what a typical provider received nationally.

https://glasscript.com/doctor/223151/gary-smith

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.